PixCell Medical Technologies
Founded Year
2009Stage
Grant - III | AliveTotal Raised
$5MAbout PixCell Medical Technologies
PixCell Medical Technologies is a privately held company developing cell-based diagnostics for the point of care (POC), based on its viscoelastic focusing and microfluidics technology. The company's core technology is comprised of an analyzer and a self-contained disposable cartridge. On May 3, 2021, PixCell Medical Technologies was acquired by Soulbrain. The terms of the transaction were not disclosed.
Compete with PixCell Medical Technologies?
Ensure that your company and products are accurately represented on our platform.
PixCell Medical Technologies's Products & Differentiators
HemoScreen
HemoScreen is the only FDA-cleared, cartridge-based platform intended for use at the point-of-care that can deliver lab-quality, full five-part differential Complete Blood Count (CBC) results. Leveraging PixCell’s patented Viscoelastic Focusing technology, along with AI-powered machine vision, HemoScreen shortens diagnostic results delivery from days to minutes. With just one drop of blood and within five minutes, HemoScreen delivers accurate readings of 20 standard blood count parameters, saving patients, clinicians, and health systems significant time and costs. HemoScreen requires no reagent handling, no calibrations, and is robust enough to be truly mobile.
Expert Collections containing PixCell Medical Technologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
PixCell Medical Technologies is included in 5 Expert Collections, including Medical Devices.
Medical Devices
11,693 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Digital Health
13,069 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Health Monitoring & Diagnostics
1,017 items
Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting
Health IT
8,264 items
PixCell Medical Technologies Patents
PixCell Medical Technologies has filed 15 patents.
The 3 most popular patent topics include:
- Fluid dynamics
- Aerodynamics
- Blood tests
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
4/1/2020 | 6/14/2022 | Fluid dynamics, Medical testing equipment, Mass spectrometry, Laboratory equipment, Blood tests | Grant |
Application Date | 4/1/2020 |
|---|---|
Grant Date | 6/14/2022 |
Title | |
Related Topics | Fluid dynamics, Medical testing equipment, Mass spectrometry, Laboratory equipment, Blood tests |
Status | Grant |
Latest PixCell Medical Technologies News
May 5, 2021
May 4, 2021 Soulbrain Holdings Co. Ltd. ramped up its unusual diversification program with the acquisition of Pixcell Medical Technologies Ltd. as part of the semiconductor company's shift into health care and in vitro diagnostics. The acquisition of Pixcell follows Soulbrain’s acquisition of Ark Diagnostics Inc. in 2018 as the company looks to the bio-health care industry as its "engine for new growth."
PixCell Medical Technologies Frequently Asked Questions (FAQ)
When was PixCell Medical Technologies founded?
PixCell Medical Technologies was founded in 2009.
Where is PixCell Medical Technologies's headquarters?
PixCell Medical Technologies's headquarters is located at 6 Hayezira St. – Aspen Building, Yokneam.
What is PixCell Medical Technologies's latest funding round?
PixCell Medical Technologies's latest funding round is Grant - III.
How much did PixCell Medical Technologies raise?
PixCell Medical Technologies raised a total of $5M.
Who are the investors of PixCell Medical Technologies?
Investors of PixCell Medical Technologies include Israel Innovation Authority, Soulbrain, European Commission and Horizon 2020.
Who are PixCell Medical Technologies's competitors?
Competitors of PixCell Medical Technologies include Sight Diagnostics and 2 more.
What products does PixCell Medical Technologies offer?
PixCell Medical Technologies's products include HemoScreen.
Who are PixCell Medical Technologies's customers?
Customers of PixCell Medical Technologies include Axonlab, Aidian, Triolab, Gamidor and New South Wales Health (Australian HMO).
Compare PixCell Medical Technologies to Competitors
OncoHost combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. Utilizing proprietary proteomic analysis, the company aims to understand patients' unique response to therapy and overcome one of the major obstacles in clinical oncology: resistance to therapy. OncoHost's host response profiling platform, PROphet®, analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient (i.e. the host) in response to a given cancer therapy. This proteomic profile is highly predictive of individual patient outcome, thus enabling personalized treatment planning. PROphet® also identifies potential drug targets, advancing the development of therapeutic strategies, as well as rationally-based combination therapies. The company was founded in 2017 and is based in Binyamina, Israel.
Truvian Sciences is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop system produces lab-accurate results for a full suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian's system delivers an alternative to off-site labs, providing immediate insights to inform healthcare decisions.
Haemonetics is a medical device company. It had developed the Haemonetics Cell Saver Elite Autotransfusion System.Haemonetics is a global company that markets automated blood processing systems. These systems help increase the safety, quality and availability of the world blood supply by addressing important medical markets: surgical blood salvage, blood component collections and plasma collections.
Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The company’s technology development program culminated in an instrument-free, single-use PCR platform that rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. Visby Medical technology also offers the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. It was founded in 2015 and is based in San Jose, California.
HealthCube transforms healthcare delivery and makes diagnosis simple and hassle-free. Despite advancements in medicine and diagnostic technology, there is a lack of quality tools to aid diagnosis in many clinical settings. The company aims to enable timely, patient-centric interventions that protect health, save time, and reduce the cost of healthcare.
Spotlab develops an ecosystem of portable devices connected and controlled with a smartphone to acquire medical images. It is a platform to diagnose remotely, and an artificial intelligence and crowdsourcing assistant that automates part of the analysis of the images.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.